Pentwater Capital Management LP Horizon Therapeutics Public LTD CO Put Options Transaction History

Pentwater Capital Management LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $499 Million - $584 Million	5,042,500 Added 50.93%	14,942,500 $1.73 Billion
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $819 Million - $955 Million	8,500,000 Added 607.14%	9,900,000 $1.02 Billion
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $147 Million - $156 Million	-1,371,700 Reduced 49.49%	1,400,000 $153 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $173 Million - $315 Million	2,771,700 New	2,771,700 $315 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Pentwater Capital Management LP with notifications on news.